Literature DB >> 31591168

Splenic Innate B1 B Cell Plasmablasts Produce Sustained Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-3 Cytokines during Murine Malaria Infections.

Shu Shien Chin1, Laurent Chorro1, John Chan1,2, Grégoire Lauvau3.   

Abstract

The physiopathology of malaria, one of the most deadly human parasitic diseases worldwide, is complex, as it is a systemic disease involving multiple parasitic stages and hosts and leads to the activation of numerous immune cells and release of inflammatory mediators. While some cytokines increased in the blood of patients infected with Plasmodium falciparum have been extensively studied, others, such as granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 (IL-3), have not received much attention. GM-CSF and IL-3 belong to the β common (βc/CD131) chain family of cytokines, which exhibit pleiotropic functions, including the regulation of myeloid cell growth, differentiation, and activation. GM-CSF can be secreted by multiple cell types, whereas IL-3 is mostly restricted to T cells, yet innate response activator (IRA) B cells, a subset of innate B1 B cells, also produce significant amounts of these cytokines during bacterial sepsis via Toll-like receptor 4 (TLR4)/MyD88 sensing of lipopolysaccharides. Herein, using murine models of malaria, we report a sustained production of GM-CSF and IL-3 from IgM+ and IgM-/IgG+ CD138+ Blimp-1+ innate B1b B cell plasmablasts. IgM+ B1b B cells include IRA-like and non-IRA B cells and express higher levels of both cytokines than do their IgG+ counterparts. Interestingly, as infection progresses, the relative proportion of IgM+ B1 B cells decreases while that of IgG+ plasmablasts increases, correlating with potential isotype switching of GM-CSF- and IL-3-producing IgM+ B1 B cells. GM-CSF/IL-3+ B1 B cells originate in the spleen of infected mice and are partially dependent on type I and type II interferon signaling to produce both cytokines. These data reveal that GM-CSF and IL-3 are produced during malaria infections, initially from IgM+ and then from IgG+ B1b B cell plasmablasts, which may represent important emergency cellular sources of these cytokines. These results further highlight the phenotypic heterogeneity of innate B1 B cell subsets and of their possible fates in a relevant murine model of parasitic infection in vivo.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  B1 B cells; GM-CSF; IL-3; IRA B cells; Plasmodiumzzm321990; interferon gamma; malaria; plasmablasts; type I interferon

Mesh:

Substances:

Year:  2019        PMID: 31591168      PMCID: PMC6867857          DOI: 10.1128/IAI.00482-19

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Innate immune responses to human malaria: heterogeneous cytokine responses to blood-stage Plasmodium falciparum correlate with parasitological and clinical outcomes.

Authors:  Michael Walther; John Woodruff; Fanny Edele; David Jeffries; Jon E Tongren; Elizabeth King; Laura Andrews; Philip Bejon; Sarah C Gilbert; Joseph B De Souza; Robert Sinden; Adrian V S Hill; Eleanor M Riley
Journal:  J Immunol       Date:  2006-10-15       Impact factor: 5.422

2.  Innate response activator B cells protect against microbial sepsis.

Authors:  Philipp J Rauch; Aleksey Chudnovskiy; Clinton S Robbins; Georg F Weber; Martin Etzrodt; Ingo Hilgendorf; Elizabeth Tiglao; Jose-Luiz Figueiredo; Yoshiko Iwamoto; Igor Theurl; Rostic Gorbatov; Michael T Waring; Adam T Chicoine; Majd Mouded; Mikael J Pittet; Matthias Nahrendorf; Ralph Weissleder; Filip K Swirski
Journal:  Science       Date:  2012-01-12       Impact factor: 47.728

3.  Innate response activator B cells aggravate atherosclerosis by stimulating T helper-1 adaptive immunity.

Authors:  Ingo Hilgendorf; Igor Theurl; Louisa M S Gerhardt; Clinton S Robbins; Georg F Weber; Ayelet Gonen; Yoshiko Iwamoto; Norbert Degousee; Tobias A W Holderried; Carla Winter; Andreas Zirlik; Herbert Y Lin; Galina K Sukhova; Jagdish Butany; Barry B Rubin; Joseph L Witztum; Peter Libby; Matthias Nahrendorf; Ralph Weissleder; Filip K Swirski
Journal:  Circulation       Date:  2014-01-31       Impact factor: 29.690

4.  Levels of stem cell factor and interleukin-3 in serum in acute Plasmodium falciparum malaria.

Authors:  H Burgmann; S Looareesuwan; E C Wiesinger; W Winter; W Graninger
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

5.  Naturally Acquired Antibodies Target the Glutamate-Rich Protein on Intact Merozoites and Predict Protection Against Febrile Malaria.

Authors:  Ikhlaq Hussain Kana; Bright Adu; Régis Wendpayangde Tiendrebeogo; Susheel Kumar Singh; Daniel Dodoo; Michael Theisen
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

6.  Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls.

Authors:  K E Lyke; R Burges; Y Cissoko; L Sangare; M Dao; I Diarra; A Kone; R Harley; C V Plowe; O K Doumbo; M B Sztein
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

7.  Role of gamma interferon during infection with Plasmodium chabaudi chabaudi.

Authors:  S J Meding; S C Cheng; B Simon-Haarhaus; J Langhorne
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

8.  Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection.

Authors:  Noah S Butler; Jacqueline Moebius; Lecia L Pewe; Boubacar Traore; Ogobara K Doumbo; Lorraine T Tygrett; Thomas J Waldschmidt; Peter D Crompton; John T Harty
Journal:  Nat Immunol       Date:  2011-12-11       Impact factor: 25.606

9.  STING-Licensed Macrophages Prime Type I IFN Production by Plasmacytoid Dendritic Cells in the Bone Marrow during Severe Plasmodium yoelii Malaria.

Authors:  Emily Spaulding; David Fooksman; Jamie M Moore; Alex Saidi; Catherine M Feintuch; Boris Reizis; Laurent Chorro; Johanna Daily; Grégoire Lauvau
Journal:  PLoS Pathog       Date:  2016-10-28       Impact factor: 6.823

10.  Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axis.

Authors:  Georg F Weber; Benjamin G Chousterman; Ingo Hilgendorf; Clinton S Robbins; Igor Theurl; Louisa M S Gerhardt; Yoshiko Iwamoto; Tam D Quach; Muhammad Ali; John W Chen; Thomas L Rothstein; Matthias Nahrendorf; Ralph Weissleder; Filip K Swirski
Journal:  J Exp Med       Date:  2014-05-12       Impact factor: 14.307

View more
  5 in total

1.  Single-cell transcriptome profiling and the use of AID deficient mice reveal that B cell activation combined with antibody class switch recombination and somatic hypermutation do not benefit the control of experimental trypanosomosis.

Authors:  Hang Thi Thu Nguyen; Robin B Guevarra; Stefan Magez; Magdalena Radwanska
Journal:  PLoS Pathog       Date:  2021-11-11       Impact factor: 6.823

2.  Mouse innate-like B-1 lymphocytes promote inhaled particle-induced in vitro granuloma formation and inflammation in conjunction with macrophages.

Authors:  Léa Hiéronimus; Raïssa Demazy; Laura Christiaens; Francine Uwambayinema; Jean-François Geuens; Youssof Yacoub; François Huaux
Journal:  Arch Toxicol       Date:  2021-12-21       Impact factor: 5.153

3.  Intracellular flow cytometry staining of antibody-secreting cells using phycoerythrin-conjugated antibodies: pitfalls and solutions.

Authors:  Patrick Renner; Michael Crone; Matthew Kornas; KimAnh T Pioli; Peter D Pioli
Journal:  Antib Ther       Date:  2022-06-10

4.  X-linked immunodeficient (XID) mice exhibit high susceptibility to Cryptococcus gattii infection.

Authors:  Israel Diniz-Lima; Pablo Rodrigo da Rosa; Elias Barbosa da Silva-Junior; Joyce Cristina Guimarães-de-Oliveira; Elisangela Oliveira de Freitas; Danielle de Oliveira Nascimento; Alexandre Morrot; Leonardo Nimrichter; Jose Osvaldo Previato; Lucia Mendonça-Previato; Leonardo Freire-de-Lima; Debora Decote-Ricardo; Celio Geraldo Freire-de-Lima
Journal:  Sci Rep       Date:  2021-09-15       Impact factor: 4.379

Review 5.  The Forgotten Brother: The Innate-like B1 Cell in Multiple Sclerosis.

Authors:  Saar T Halperin; Bert A 't Hart; Antonio Luchicchi; Geert J Schenk
Journal:  Biomedicines       Date:  2022-03-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.